Clinical trials for disease modifying therapies are emerging for frontotemporal degeneration (FTD). The current trials are focused on FTD caused by specific genetic changes. With that, comes an interest in understanding the experience of people impacted by genetic FTD.
No takes yet. Share an insight, caveat, or question.
Dodge et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: